Jiangxi Fushine Pharmaceutical Hits Day Low Amid Price Pressure at CNY 16.99

Jiangxi Fushine Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 6.77% and reaching an intraday low of CNY 16.99. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 2.06% on the same day. Over the past week, Jiangxi Fushine has seen a more significant downturn, with a 17.57% decrease, while its monthly performance remains positive at 8.31%. Year-to-date, the stock has gained 13.04%, and over the past year, it has delivered an impressive return of 77.55%, significantly outperforming the China Shanghai Composite's 11.5% increase. Despite these fluctuations, the company has demonstrated strong growth in net profit, with a remarkable increase of 692.07% reported in its latest results. However, long-term fundamentals show some weaknesses, including a return on capital employed (ROCE) of just 4.17% and a decline in net sales over the past five years. Jiangxi Fushine remains net-debt free, which may provide some stability amid the current market volatility.